Cargando…
Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations in Small Cell Lung Cancer
Small cell lung cancer (SCLC) is an aggressive type of lung cancer, and the detection of SCLCs at an early stage is necessary for successful therapy and for improving cancer survival rates. Fucosylation is one of the most common glycosylation-based modifications. Increased levels of fucosylation hav...
Autores principales: | Ahn, Jung-Mo, Sung, Hye-Jin, Yoon, Yeon-Hee, Kim, Byung-Gyu, Yang, Won Suk, Lee, Cheolju, Park, Hae-Min, Kim, Bum-Jin, Kim, Byung-Gee, Lee, Soo-Youn, An, Hyun-Joo, Cho, Je-Yoel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879622/ https://www.ncbi.nlm.nih.gov/pubmed/24085812 http://dx.doi.org/10.1074/mcp.M113.028621 |
Ejemplares similares
-
Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells
por: Aldonza, Mark Borris D., et al.
Publicado: (2017) -
Multi-targeted therapy resistance via drug-induced secretome fucosylation
por: Aldonza, Mark Borris D, et al.
Publicado: (2023) -
Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA
por: Wang, Ce, et al.
Publicado: (2019) -
Pattern identification of lung cancer patients based on body constitution questionnaires (BCQ) and glycoproteomics for precision medicine
por: Cho, Wonryeon, et al.
Publicado: (2019) -
Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability but Is Associated with Clinical Outcome after PCI
por: Park, Kyung Woo, et al.
Publicado: (2013)